Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and ...
Q2 2026
Aug 6, 2026
Q1 2026
May 6, 2026
FY 2025
Feb 25, 2026
Q4 2025
Q3 2025
Nov 6, 2025